Immunohistochemically (IHC) staining with WDR12 antibody in a human glioma tissue microarray showed that both the intensity of WDR12 staining and the percentage of WDR12 positive cells were strongly increased in high-grade gliomas compared to low-grade gliomas (Figure 5E). This evidence concerns the gene WDR12 and central nervous system cancer.